FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2977843586> ?p ?o ?g. }

• W2977843586 endingPage "85" @default.
• W2977843586 startingPage "76" @default.
• W2977843586 abstract "BACKGROUND An elevated neutrophil-to-lymphocyte ratio (NLR) is associated with poor survival in patients with cancer, including those who receive immunotherapies. The authors sought to investigate NLR as a biomarker of treatment outcomes in patients with melanoma who were treated with PD-1 inhibition. METHODS Patients undergoing initial treatment with PD-1 inhibitor monotherapy for stage IV melanoma at a single center from 2012 to 2015 were included. Clinical characteristics and the NLR at baseline and before subsequent treatment cycles were collected. The time to treatment failure (TTF) and overall survival (OS) were evaluated using Kaplan-Meier and landmark analyses. RESULTS Among 224 study patients, 63 (28%) had a baseline NLR ≥5. The baseline NLR was significantly associated with Eastern Cooperative Oncology Group performance status and the number of involved metastatic sites. With a median follow-up of 39 months in survivors, a baseline NLR ≥5 was independently associated with shorter OS (hazard ratio, 2.0; 95% CI, 1.3-2.9) and TTF (hazard ratio, 1.7; 95% CI, 1.2-2.4). An NLR increase ≥30% during the first 2 cycles of treatment was associated with worse OS (median, 47 vs 13.5 months; P < .001) and a trend toward shorter TTF (12.8 vs 5.9 months; P = .05). A combined baseline NLR ≥5 and an NLR increase ≥30% identified a small cohort with markedly shortened OS (median, 5.8 months) and TTF (median, 1.8 months). CONCLUSIONS Elevated baseline NLR and an increased NLR early during treatment are prognostic for TTF and OS in patients who have melanoma treated with PD-1 inhibitor monotherapy. Combined, these biomarkers can widely risk-stratify patients for treatment failure and survival." @default.
• W2977843586 created "2019-10-10" @default.
• W2977843586 creator A5002954478 @default.
• W2977843586 creator A5002965160 @default.
• W2977843586 creator A5011325668 @default.
• W2977843586 creator A5020744715 @default.
• W2977843586 creator A5021407180 @default.
• W2977843586 creator A5038180626 @default.
• W2977843586 creator A5085724926 @default.
• W2977843586 creator A5089724606 @default.
• W2977843586 date "2019-10-04" @default.
• W2977843586 modified "2023-10-15" @default.
• W2977843586 title "High neutrophil‐to‐lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD‐1 inhibitor monotherapy" @default.
• W2977843586 cites W1870093969 @default.
• W2977843586 cites W1976156978 @default.
• W2977843586 cites W1982906652 @default.
• W2977843586 cites W1992226123 @default.
• W2977843586 cites W2017381571 @default.
• W2977843586 cites W2029199150 @default.
• W2977843586 cites W2040620505 @default.
• W2977843586 cites W2043904711 @default.
• W2977843586 cites W2067931754 @default.
• W2977843586 cites W2088728082 @default.
• W2977843586 cites W2154361786 @default.
• W2977843586 cites W2270932386 @default.
• W2977843586 cites W2287205515 @default.
• W2977843586 cites W2397092478 @default.
• W2977843586 cites W2411767313 @default.
• W2977843586 cites W2517455019 @default.
• W2977843586 cites W2531648809 @default.
• W2977843586 cites W2581283430 @default.
• W2977843586 cites W2595873134 @default.
• W2977843586 cites W2596958521 @default.
• W2977843586 cites W2597476871 @default.
• W2977843586 cites W2749408522 @default.
• W2977843586 cites W2783295481 @default.
• W2977843586 cites W2789677706 @default.
• W2977843586 cites W2791745418 @default.
• W2977843586 cites W2802206159 @default.
• W2977843586 cites W2806349817 @default.
• W2977843586 cites W2883706035 @default.
• W2977843586 cites W2890875511 @default.
• W2977843586 cites W2896135215 @default.
• W2977843586 doi "https://doi.org/10.1002/cncr.32506" @default.
• W2977843586 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6906249" @default.
• W2977843586 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31584709" @default.
• W2977843586 hasPublicationYear "2019" @default.
• W2977843586 type Work @default.
• W2977843586 sameAs 2977843586 @default.
• W2977843586 citedByCount "80" @default.
• W2977843586 countsByYear W29778435862020 @default.
• W2977843586 countsByYear W29778435862021 @default.
• W2977843586 countsByYear W29778435862022 @default.
• W2977843586 countsByYear W29778435862023 @default.
• W2977843586 crossrefType "journal-article" @default.
• W2977843586 hasAuthorship W2977843586A5002954478 @default.
• W2977843586 hasAuthorship W2977843586A5002965160 @default.
• W2977843586 hasAuthorship W2977843586A5011325668 @default.
• W2977843586 hasAuthorship W2977843586A5020744715 @default.
• W2977843586 hasAuthorship W2977843586A5021407180 @default.
• W2977843586 hasAuthorship W2977843586A5038180626 @default.
• W2977843586 hasAuthorship W2977843586A5085724926 @default.
• W2977843586 hasAuthorship W2977843586A5089724606 @default.
• W2977843586 hasBestOaLocation W29778435861 @default.
• W2977843586 hasConcept C121608353 @default.
• W2977843586 hasConcept C126322002 @default.
• W2977843586 hasConcept C143998085 @default.
• W2977843586 hasConcept C169382597 @default.
• W2977843586 hasConcept C203014093 @default.
• W2977843586 hasConcept C2777658100 @default.
• W2977843586 hasConcept C2777701055 @default.
• W2977843586 hasConcept C2777761686 @default.
• W2977843586 hasConcept C2778963024 @default.
• W2977843586 hasConcept C2781053074 @default.
• W2977843586 hasConcept C502942594 @default.
• W2977843586 hasConcept C71924100 @default.
• W2977843586 hasConcept C90924648 @default.
• W2977843586 hasConceptScore W2977843586C121608353 @default.
• W2977843586 hasConceptScore W2977843586C126322002 @default.
• W2977843586 hasConceptScore W2977843586C143998085 @default.
• W2977843586 hasConceptScore W2977843586C169382597 @default.
• W2977843586 hasConceptScore W2977843586C203014093 @default.
• W2977843586 hasConceptScore W2977843586C2777658100 @default.
• W2977843586 hasConceptScore W2977843586C2777701055 @default.
• W2977843586 hasConceptScore W2977843586C2777761686 @default.
• W2977843586 hasConceptScore W2977843586C2778963024 @default.
• W2977843586 hasConceptScore W2977843586C2781053074 @default.
• W2977843586 hasConceptScore W2977843586C502942594 @default.
• W2977843586 hasConceptScore W2977843586C71924100 @default.
• W2977843586 hasConceptScore W2977843586C90924648 @default.
• W2977843586 hasFunder F4320337351 @default.
• W2977843586 hasIssue "1" @default.
• W2977843586 hasLocation W29778435861 @default.
• W2977843586 hasLocation W29778435862 @default.
• W2977843586 hasLocation W29778435863 @default.
• W2977843586 hasOpenAccess W2977843586 @default.
• W2977843586 hasPrimaryLocation W29778435861 @default.
• W2977843586 hasRelatedWork W2138021333 @default.

• next